Vikas Sinha

CIK: 0001337845

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)17 (54.8%)

Position reduction

Option Exercises (M)7 (22.6%)

Derivative conversions

Awards (A)5 (16.1%)

Compensation grants

Other (G, F, J, C, D, …)2 (6.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

SRRK

Scholar Rock Holding Corp

Officer

VRNA

Verona Pharma plc

Director

ALVR

Allovir, Inc.

DirectorOfficer10% Owner

Discretionary Trading P&L

Holdings

Transaction History (31 total)

SRRK
Scholar Rock Holding Corp
Apr 16, 2026
Sale(S)
Direct
10.4K shares at avg. $49.57$516K
SRRK
Scholar Rock Holding Corp
Feb 9, 2026
Award(A)
Direct
47K shares-
SRRK
Scholar Rock Holding Corp
Jan 13, 2026
Sale(S)
Direct
16.8K shares at avg. $42.70$715K
VRNA
Verona Pharma plc
Oct 7, 2025
Disposition(D)
Direct
94.1K shares-
VRNA
Verona Pharma plc
Oct 7, 2025
Exercise(M)
Direct
72K shares-
VRNA
Verona Pharma plc
Oct 7, 2025
Disposition(D)
Direct
72K shares-
VRNA
Verona Pharma plc
Aug 1, 2025
Sale(S)
Direct
4.3K shares at avg. $13.14$57K
VRNA
Verona Pharma plc
Aug 1, 2025
Exercise(M)
Direct
24K shares-
VRNA
Verona Pharma plc
May 20, 2025
Sale(S)
Direct
160K shares at avg. $9.39$1.5M
VRNA
Verona Pharma plc
May 20, 2025
Exercise(M)
Direct
160K shares at avg. $0.50$81K
SRRK
Scholar Rock Holding Corp
May 2, 2025
Award(A)
Stock Option (Right to Buy)
Direct
110.1K shares-
VRNA
Verona Pharma plc
Apr 29, 2025
Sale(S)
Direct
39.6K shares at avg. $8.92$353K
VRNA
Verona Pharma plc
Apr 29, 2025
Sale(S)
Direct
120.4K shares at avg. $8.92$1.1M
VRNA
Verona Pharma plc
Apr 29, 2025
Exercise(M)
Direct
120.4K shares at avg. $1.70$205K
VRNA
Verona Pharma plc
Apr 29, 2025
Exercise(M)
Direct
39.6K shares at avg. $0.50$20K
VRNA
Verona Pharma plc
Apr 29, 2025
Exercise(M)
Direct
15K shares at avg. $1.70$26K
VRNA
Verona Pharma plc
Apr 29, 2025
Sale(S)
Direct
15K shares at avg. $8.92$134K
VRNA
Verona Pharma plc
Apr 29, 2025
Exercise(M)
Direct
5K shares at avg. $0.50$2K
VRNA
Verona Pharma plc
Apr 29, 2025
Sale(S)
Direct
5K shares at avg. $8.92$44K
SRRK
Scholar Rock Holding Corp
Apr 27, 2025
Award(A)
Direct
500K shares-
SRRK
Scholar Rock Holding Corp
Apr 27, 2025
Award(A)
Direct
100K shares-
VRNA
Verona Pharma plc
Apr 25, 2025
Award(A)
Restricted Share Units
Direct
96K shares-
ALVR
Allovir, Inc.
Feb 21, 2025
Sale(S)
Direct
303 shares at avg. $10.08$3K
ALVR
Allovir, Inc.
Jan 23, 2025
Sale(S)
Direct
13 shares at avg. $9.94$129.223
ALVR
Allovir, Inc.
Jan 23, 2025
Sale(S)
Direct
116 shares at avg. $9.45$1K

		Type	Shares	Price		Ownership
Apr 16, 2026	SRRK Scholar Rock Holding Corp	Sale(S)	10,410	$49.57	$516,071	Direct
Feb 9, 2026	SRRK Scholar Rock Holding Corp	Award(A)	47,021	-	$0	Direct
Jan 13, 2026	SRRK Scholar Rock Holding Corp	Sale(S)	16,755	$42.70	$715,439	Direct
Oct 7, 2025	VRNA Verona Pharma plc	Disposition(D)	94,112	-	-	Direct
Oct 7, 2025	VRNA Verona Pharma plc	Exercise(M)	72,000	-	-	Direct
Oct 7, 2025	VRNA Verona Pharma plc	Disposition(D)	72,000	-	-	Direct
Aug 1, 2025	VRNA Verona Pharma plc	Sale(S)	4,328	$13.14	$56,886	Direct
Aug 1, 2025	VRNA Verona Pharma plc	Exercise(M)	24,000	-	-	Direct
May 20, 2025	VRNA Verona Pharma plc	Sale(S)	160,000	$9.39	$1,502,928	Direct
May 20, 2025	VRNA Verona Pharma plc	Exercise(M)	160,000	$0.50	$80,608	Direct
May 2, 2025	SRRK Scholar Rock Holding Corp	Award(A) Stock Option (Right to Buy)	110,067	-	-	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Sale(S)	39,616	$8.92	$353,406	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Sale(S)	120,384	$8.92	$1,073,922	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Exercise(M)	120,384	$1.70	$204,653	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Exercise(M)	39,616	$0.50	$19,959	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Exercise(M)	15,048	$1.70	$25,582	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Sale(S)	15,048	$8.92	$134,240	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Exercise(M)	4,952	$0.50	$2,495	Direct
Apr 29, 2025	VRNA Verona Pharma plc	Sale(S)	4,952	$8.92	$44,176	Direct
Apr 27, 2025	SRRK Scholar Rock Holding Corp	Award(A)	500,000	-	-	Direct
Apr 27, 2025	SRRK Scholar Rock Holding Corp	Award(A)	100,000	-	-	Direct
Apr 25, 2025	VRNA Verona Pharma plc	Award(A) Restricted Share Units	96,000	-	-	Direct
Feb 21, 2025	ALVR Allovir, Inc.	Sale(S)	303	$10.08	$3,053	Direct
Jan 23, 2025	ALVR Allovir, Inc.	Sale(S)	13	$9.94	$129	Direct
Jan 23, 2025	ALVR Allovir, Inc.	Sale(S)	116	$9.45	$1,097	Direct

1-25 of 31 transactions

About Sinha Vikas

Sinha Vikas (SEC CIK 0001337845) files insider reports with the SEC as Chief Financial Officer of Scholar Rock Holding Corp (SRRK), Director of Verona Pharma plc (VRNA) and Director of Allovir, Inc. (ALVR).

Signal8 holds 19 ownership filings by Sinha Vikas (1 Form 3, 18 Form 4), filed between Oct 4, 2024 and Apr 20, 2026. Those filings report 31 transactions, from Oct 3, 2024 to Apr 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Sinha Vikas's filings is in CAMBRIDGE, MA.

Recent filings by Sinha Vikas

Apr 16, 2026: Open-market sale of SRRK shares (Form 4, code S).
Feb 9, 2026: Grant or award of SRRK shares (Form 4, code A).
Jan 13, 2026: Open-market sale of SRRK shares (Form 4, code S).
Oct 7, 2025: Disposition to issuer transaction of VRNA shares (Form 4, code D).
Oct 7, 2025: Option exercise of VRNA shares (Form 4, code M).

Other insiders filing for Scholar Rock Holding Corp (SRRK)

AKKARAJU SRINIVAS, Director
Woods Keith, Chief Operating Officer
Hallal David, Chief Executive Officer
FLIER JEFFREY S., Director
Gilman Michael, Director
Burow Kristina, Director

How to read Form 4 transaction codes